(Total Views: 799)
Posted On: 12/28/2024 3:20:04 AM
Post# of 153902
Posted By: Figgs
Looking forward to the day when someone is diagnosed with breast cancer they are immediately given a shot Leronlimab to block cellular metastasis. It seems like such a pity this isn't just available now.
_________________________________________
So true Figgs.
At the risk of TMI, was diagnosed with breast cancer a while back. (Very fortunate- small, early and HR+.) My first visit to an oncologist, I brought a one page summary of the MOA/highlights/ main resources of leronlimab. Wanted to introduce him to leron and beg him for a way to get access to it.
Long story short...he was visibly agitated but did quickly search for the clinical trials. He basically saw it as me questioning his competence and said that he was a good oncologist that only used approved treatments. Having the doc frustrated with you is not the place you want to be as a cancer patient and it took a while to mend things.
100 percent looking forward to the day when the docs are doing the introductions.
Looking forward to the day when someone is diagnosed with breast cancer they are immediately given a shot Leronlimab to block cellular metastasis. It seems like such a pity this isn't just available now.
_________________________________________
So true Figgs.
At the risk of TMI, was diagnosed with breast cancer a while back. (Very fortunate- small, early and HR+.) My first visit to an oncologist, I brought a one page summary of the MOA/highlights/ main resources of leronlimab. Wanted to introduce him to leron and beg him for a way to get access to it.
Long story short...he was visibly agitated but did quickly search for the clinical trials. He basically saw it as me questioning his competence and said that he was a good oncologist that only used approved treatments. Having the doc frustrated with you is not the place you want to be as a cancer patient and it took a while to mend things.
100 percent looking forward to the day when the docs are doing the introductions.
(30)
(0)
